SCHEMBL2861016

SCHEMBL2861016

CC(=O)Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1

nearest known ligand 0.68

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ITK Q08881 9/20 0.68
TTK P33981 5/20 0.62
MAPK8 P45983 2/20 0.58
MAPKAPK2 P49137 1/20 0.56
UTRN P46939 1/20 0.52
KDM4E B2RXH2 1/20 0.50
MTNR1A P48039 1/20 0.50
MTNR1B P49286 1/20 0.50
KMT2A Q03164 1/20 0.50
AURKA O14965 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2864712 0.87 ITK (0.56) ITKTTKMAPKAPK2KDM4EKMT2A
SCHEMBL8260089 0.86 TTK (0.69) ITKTTKMAPK8KDM4EMTNR1A
SCHEMBL2871320 0.84 PDPK1 (0.66) ITKMAPKAPK2
SCHEMBL2862749 0.83 MAPKAPK2 (0.50) ITKTTKMAPK8MAPKAPK2AURKA
SCHEMBL2862144 0.83 MAPKAPK2 (0.50) ITKTTKMAPK8MAPKAPK2AURKA
SCHEMBL2867415 0.81 ULK1 (0.64) ITKMAPKAPK2
SCHEMBL2869945 0.81 TTK (0.67) ITKTTKMAPKAPK2KDM4EKMT2A
SCHEMBL2866378 0.81 ITK (0.59) ITKTTKMAPKAPK2AURKA
SCHEMBL2868361 0.80 AURKA (0.50) ITKTTKMAPKAPK2KMT2AAURKA
SCHEMBL2870858 0.80 ITK (0.57) ITKMAPKAPK2KMT2AAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
CN-1300116-C 1H-indazole compounds EISAI CO LTD (JP) 2007-02-14 CN disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
CN-1512987-A Novel 1H-indazole compound ������������ʽ���� 2004-07-14 CN disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ITK 3726/4885TTK 1201/4885MAPK8 10/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 ITK 3628/4885TTK 1066/4885MAPK8 9/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 ITK 3726/4885TTK 1201/4885MAPK8 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.